oasis 1 trial oral semaglutide 50 mg obesity lancet 2023 Effect of on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled - Gabe - 2024 - Diabetes, and Metabolism Emerging pharmacotherapies for obesity: A

& Costagliola, S

Conclusions and Discussion In conclusion, this study presents a novel approach for the site-specific enzymatic incorporation of ornithine at position 8 of the semaglutide, resulting in the first ornithine-modified semaglutide analogue

GLP-1 has several important functions (Mozzafariun et al 2025): Slows stomach emptying, helping you feel fuller longer Stimulates insulin release and helps lower blood sugar after meals Reduces appetite and food intake giving you a clear stop eating signal

This makes the injection form an excellent choice if birth control interaction is a concern for you

Rising awareness of obesity-related risks further boosts uptake

Von Der Werth J, Williams H